Scitech Development, Inc.
Clinical trials sponsored by Scitech Development, Inc., explained in plain language.
-
New IV drug trial offers hope for patients with aggressive lymphoma
Disease control Recruiting nowThis is an early-stage study testing a new intravenous drug called ST-001 for people with T-cell lymphoma that has come back or not responded to prior treatments. The main goals are to find the highest safe dose and understand how the drug works in the body. It is for adults whos…
Phase: PHASE1 • Sponsor: SciTech Development, Inc. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New hope for tough lung cancer: first patients test novel IV treatment
Disease control Recruiting nowThis early-stage trial is testing a new intravenous drug called ST-001 for people with small cell lung cancer that has returned or stopped responding to standard treatments. The main goals are to find the highest safe dose and understand how the drug moves through the body. Resea…
Phase: PHASE1 • Sponsor: SciTech Development, Inc. • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC